Folgen
-
Chronic venous disease, which affects almost 70% of the population, has recently been proved to be associated with increased prevalence of cardiovascular risk factors and all-cause death. We explore the evidence sustaining this statement, potential pathophysiological pathways underlying the association, and implications for everyday clinical practice with Dr. Joana Ferreira. You'll be surprised, and inspired, by this paradigm shift!
-
This podcast with Prof. Robert Hinchliffe and Prof. Stephen Black gives some extra information on the EVeR registry, an initiative aimed at advancing our understanding and treatment of venous diseases. This registry is a collaborative effort between leading vascular specialists, researchers, and healthcare institutions across Europe. The registry was developed in collaboration with the European Vascular Research Collaborative (EVRC).
Deep venous diseases affect millions of people worldwide. Despite their prevalence, many aspects of these conditions remain poorly understood. EVeR will play a crucial role in addressing this knowledge gap by:
- Collecting comprehensive data: Gathering detailed information on patients with venous diseases, including their symptoms, medical history, treatments, and outcomes.
- Evaluating treatment effectiveness: Assessing the efficacy of different treatment options for venous diseases.
- Improving patient care: Ultimately, EVeR will help to improve the treatment and management of venous diseases
If you are a healthcare professional treating patients with venous diseases, we encourage you to join EVeR. By contributing data to the registry, you can help to improve the lives of patients with these conditions.
-
Fehlende Folgen?
-
Join us in this expert interview of 2024 PAD guideline Co-Author Dr. Van de Water (Maastricht) and 2023 ZILVERPASS Author Dr. Bosiers (Bern) in this timely debate.
References:
- Bosiers M, De Donato G, Torsello G, et al. ZILVERPASS study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal lesions. J Cardiovasc Surg. 2023. https://doi.org/10.23736/S0021- 9509.23.12607
- RJ Vossen, TM Fokkema, AC Vahl, and R Balm. Systematic review and meta-analysis comparing the autogenous vein bypass versus a prosthetic graft for above-the-knee femoropopliteal bypass surgery in patients with intermittent claudication. Vascular. Sept 6 2022. Vol 32 issue 1.
- Maxime Dubosq-Lebaz , Audrey Fels , Gilles Chatellier , Yann Gouëffic Systematic Review and Meta-analysis of Clinical Outcomes After Endovascular Treatment in Patients With Femoropopliteal Lesions Greater Than 150 mm. J Endovasc Ther. 2023 Sep 30:15266028231202709.
- Alik Farber et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia (BEST-CLI). N Engl J Med. 2022 Dec 22;387(25):2305-2316.
- Andrew W Bradbury et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023 May 27;401(10390):1798-1809.
- Nordanstig et al. European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg (2024) 67, 9e96)References:
- Bosiers M, De Donato G, Torsello G, et al. ZILVERPASS study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal lesions. J Cardiovasc Surg. 2023. https://doi.org/10.23736/S0021- 9509.23.12607
- RJ Vossen, TM Fokkema, AC Vahl, and R Balm. Systematic review and meta-analysis comparing the autogenous vein bypass versus a prosthetic graft for above-the-knee femoropopliteal bypass surgery in patients with intermittent claudication. Vascular. Sept 6 2022. Vol 32 issue 1.
- Maxime Dubosq-Lebaz , Audrey Fels , Gilles Chatellier , Yann Gouëffic Systematic Review and Meta-analysis of Clinical Outcomes After Endovascular Treatment in Patients With Femoropopliteal Lesions Greater Than 150 mm. J Endovasc Ther. 2023 Sep 30:15266028231202709.
- Alik Farber et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia (BEST-CLI). N Engl J Med. 2022 Dec 22;387(25):2305-2316.
- Andrew W Bradbury et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023 May 27;401(10390):1798-1809.
- Nordanstig et al. European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg (2024) 67, 9e96)
-
In this week's episode, together with a cardiologist Dr. Gisela Teixido Tura, we will try to unwrap a complex topic of aortopathies, placing a lot of focus on the success of the treatment in diagnostics of those conditions and a multidisciplinary management. Take a listen!
-
Non-technical skills have a big influence on surgical patient outcomes. For the first time, during the ESVS Annual Meeting, a specific Academy workshop was focused on this topic. In this podcast, Drs. Andrew Garnham and Rosie Darwood guide us through the concept, teaching and practice of these skills for vascular surgeons. Listen on!
-
Today’s episode is a throwback to ESVS Annual meeting in Krakow. Prof. E.Avgerinos has shared his knowledge about pelvic venous disease, while also taking opportunity to raise awarness on this condition. We focus on an overview of the disease with detailed information on pelvic embolisation- take a listen, you won’t regret it.
-
In this podcast, we talk with Drs. Melina Vega de Ceniga and Arindam Chaudhuri, former and current Editors in chief of the ESVS journal Vascular Forum, about the revamp and development of the journal, about the achievement of the impact factor, about team work, and much more!
EJVES Vascular Forum is aimed primarily at vascular surgeons dealing with patients who have arterial, venous and lymphatic diseases. The focus of the journal is to provide an inclusive multimedia platform for education, dissemination of scientific content, interactive discussion and opinion formation. It publishes case reports and case series, technical notes, original research in a medium length format, literary reviews with educational value and other commissioned educational pieces, like evidence based clinical scenarios.
Head to the European Journal of Vascular and Endovascular Surgery Vascular Forum at ejvesreports.com
-
Have you moved to a different country to do your training or to work as a consultant, or are you thinking of doing it and are wondering about the pros and cons? Well, this is exactly the topic of today’s podcast: vascular nomads. Recording from the 2024 ESVS Annual Meeting in Krakow we are grateful for the open and honest stories of Carlota Fernandez Prendes and Vaiva Dabravolskaité, living and working successfully as Vascular Nomads.
Enjoy!
-
Editor's Choice Episode: the COSTLY-TLR study evaluates the cost of revascularising PAD patients with restenosed or reoccluded stents. Laurence Bertrand interviews authors Dr. Konstantinos Stavroulakis and Prof. Dr. Athanasios Saratzis to discuss their findings and the potential consequences for clinical practice.
Enjoy!
Link to the original article:
https://www.ejves.com/article/S1078-5884(24)00160-6/fulltext
Link to references article in discussion:
https://academic.oup.com/bjsopen/article/7/6/zrad112/7343202
-
Welcome to the final episode of the Q&A series of the 2024 ESVS clinical practice guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. In this series of podcasts, we are highlighting the new, complex and most controversial recommendations in these guideline. On today’s episode we will talk about the postoperative management of AAA patients.
-
Welcome to part 2 of the Q&A series of the 2024 ESVS clinical practice guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. In this podcast, we will highlight the new, complex and most controversial recommendations in this guideline. On today’s episode we will dive deeper into the peroperative management of AAA patients.
-
Here is the first of a 3 part Q&A serie on the 2024 ESVS clinical practice guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. In this podcast, we will highlight the new, complex and most controversial recommendations in this guideline. Today for the first episode of this 3-part series, we will specifically talk about the preoperative process. The rest of the guideline will be covered in the next two episodes. We are proud to welcome 4 of the 17 members of the guideline writing committee as our guests in all three episodes; Prof. dr. Isabelle Van Herzeele, Prof. Dr. Anders Wanhainen, Dr. Frederico Bastos Gonçalves and Dr. Carlota Fernandez Prendes.
-
This week, we release the last of three podcasts recorded live during the Translational Spring Meeting in June in Stockholm. Dr. Rachael Forsythe gives us an invaluable insider's look into the emerging science of biomarkers in Aortic imaging. Where do they come from, how did we find them and what are they for? All of this and more in this weeks episode.
Here-below the referenced sources in the episode.
Enjoy!
Links:
UK vascular charities:
Circulation Foundation: www.circulationfoundation.org.uk
British Heart Foundation: www.bhf.org.uk
Relevant papers:
The SoFIA3 Study:
https://doi.org/10.1016/j.jacc.2017.11.053
The MA3RS Study: 10.1161/CIRCULATIONAHA.117.028433
18F NaF following EVAR: DOI.org https://doi.org/10.1136/heartjnl-2023-322514
Dr Marc Bailey / Dr Michael Bell (Leeds) pre-clinical 18F NaF imaging: DOI: 10.1055/s-0042-1750913
Other links:
UK Metformin Aneurysm Trial: https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/uk-mat/#:~:text=The%20Metformin%20Aneurysm%20Trial%20(MAT,repair%20and%20AAA%20mortality%20(due
Profiles:
Dr Rachael Forsythe, Edinburgh: @ROForsythe https://surgery.ed.ac.uk/staff/profiles/rachael-forsythe
Professor David Newby, Edinburgh: https://www.ed.ac.uk/profile/david-newby
-
This week, we release first of three podcasts recorded live during the Translational Spring Meeting in June in Stockholm. Vaiva Dabravolskaite had a please talking with two extraordinary physicians and scientists: Prof. Katherine McGinigle and Dr. Juliette Raffort-Lareyre. Together we will introduce concepts of machine learning, artificial intelligence and etc and will dive in deeper into different ways it can assist us in predicting risk models for patients with CLTI. Enjoy!
Arteria L’avenir de vos artères (Nice, France): https://arter-ia.com/en/ -
In this week's podcast, Prof. Martin Björck joins us to tell us all we should know about Abdominal Compartment Syndrome, a life-threatening condition characterised by increased pressure in the abdomen, leading to compromised blood flow to vital organs.
Read the Virtual Vascular chapter "Abdominal Compartment Syndrome" written by Prof. Björck on the ESVS Library.
-
This last part of the Q&A series on the ESVS 2024 PAD Guidelines, we will be discussing with the guidelines writing committee chair, Dr. Joakim Nordanstig, about invasive interventions for claudication.
The ESVS 2024 Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication is available in Open Access https://esvs.org/guidelines/
-
This second part of the Q&A series on the ESVS 2024 PAD Guidelines, we will be asking the guidelines writing committee chair, Dr. Joakim Nordanstig, about the treatment recommendations for claudication, the role of supervised exercise therapy, and more!
The ESVS 2024 Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication is available in Open Access https://esvs.org/guidelines/
-
This first part of the Q&A series on the ESVS 2024 PAD Guidelines will focus on asymptomatic patients in screening for PAD.
The guidelines writing committee chair, Dr. Joakim Nordanstig, shares the process and challenges of creating the guidelines. We also zoom in on some of the recommendations in screening approaches and the reasoning behind them.
The ESVS Guidelines is available in Open Access https://esvs.org/guidelines/
- Mehr anzeigen
